1. Home
  2. IHG vs ROIV Comparison

IHG vs ROIV Comparison

Compare IHG & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intercontinental Hotels Group

IHG

Intercontinental Hotels Group

HOLD

Current Price

$143.48

Market Cap

21.4B

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$28.32

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHG
ROIV
Founded
1777
2014
Country
United Kingdom
United Kingdom
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.4B
20.7B
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
IHG
ROIV
Price
$143.48
$28.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
N/A
$28.94
AVG Volume (30 Days)
208.4K
4.4M
Earning Date
08-02-2016
05-28-2026
Dividend Yield
1.25%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$29,053,000.00
Revenue This Year
$9.46
N/A
Revenue Next Year
$5.51
$744.61
P/E Ratio
$29.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$109.79
$10.58
52 Week High
$150.89
$30.33

Technical Indicators

Market Signals
Indicator
IHG
ROIV
Relative Strength Index (RSI) 55.87 50.77
Support Level $133.08 $26.94
Resistance Level $146.67 $30.26
Average True Range (ATR) 2.65 0.88
MACD -0.07 -0.16
Stochastic Oscillator 56.06 39.58

Price Performance

Historical Comparison
IHG
ROIV

About IHG Intercontinental Hotels Group

InterContinental Hotels Group operates 1 million rooms across 20 brands addressing the midscale through luxury segments, as of Dec. 31, 2025. Holiday Inn and Holiday Inn Express constitute the largest brand, while Hotel Indigo, Even, Hualuxe, Kimpton, and Voco are newer lifestyle brands experiencing strong demand. The company launched a midscale brand, Avid, in 2017 and closed on a 51% stake in Regent Hotels in 2018. It acquired Six Senses in 2019 and launched another midscale brand, Garner, in 2023, followed by a premium conversion brand, Noted Collections, in 2026. Managed and franchised represent 99% of total rooms. As of Dec. 31, 2025, the Americas represented 52% of total rooms, with Greater China accounting for 20% and Europe, Asia, the Middle East, and Africa making up 28%.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: